Clinical Validation and Benchmarking of Top Performing ctDNA Diagnostics - Stage III NSCLC

RecruitingOBSERVATIONAL
Enrollment

248

Participants

Timeline

Start Date

November 10, 2023

Primary Completion Date

December 1, 2025

Study Completion Date

July 31, 2030

Conditions
Lung Cancer Stage III
Interventions
DIAGNOSTIC_TEST

ctDNA

ctDNA will be tested retrospectively, no treatment decisions will be made prospectively

Trial Locations (6)

22927

NOT_YET_RECRUITING

Department of thoracic oncology- LungenClinic Großhansdorf, Großhansdorf

06000

RECRUITING

Centre Hospitalier Universitaire de Nice, Nice

06189

NOT_YET_RECRUITING

Antoine Lacassagne Center, Nice

8025AB

RECRUITING

Isala, Zwolle

9713GZ

RECRUITING

University Medical Center Groningen, Departments of Pulmonology and Pathology, Groningen

9679BJ

RECRUITING

Ommelander Ziekenhuis Groningen, Scheemda

All Listed Sponsors
collaborator

LungenClinic Grosshansdorf

OTHER

collaborator

Centre Hospitalier Universitaire de Nice

OTHER

lead

University Medical Center Groningen

OTHER